Showing results (331-340 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|August 22, 2020
Cutaneous adverse events and quality of life in outpatients receiving anticancer agents: results from an observational, cross-sectional studyHae-Jin Suh Oh, Ángeles Flórez Menéndez, Víctor Sacristán Santos, et al.Drugs in Context|April 23, 2021
Paediatrics: how to manage infantile haemangiomaJason Hs Kim, Joseph M LamDrugs in Context|April 20, 2023
Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literatureGiampiero Porzio, Andreia Capela, Raffaele Giusti, et al.Drugs in Context|October 28, 2022
Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysisMichael Kennelly, Ronald Wielage, Denise Shortino, et al.Drugs in Context|October 3, 2022
Cannabidiol as a personalized treatment for anxiety: clinical cases in MexicoFlor Cristina Ortiz Rios, Itzel Guadalupe Dávila Ruiz, Elisa Sacal DumaniDrugs in Context|December 4, 2023
Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)Abdulmajeed M Albadi, Mana M Alshahrani, Riyad O AllehebiDrugs in Context|January 8, 2024
Diuretic resistance and the role of albumin in congestive heart failureCarol Fernandez Hazim, Gustavo Duarte, Ana P Urena, et al.Drugs in Context|January 24, 2024
How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a reviewIñaki Izquierdo, Laia Casas, Susana Cabrera, et al.Drugs in Context|August 21, 2024
Sublingually administered bacterial lysates: rationale, mechanisms of action and clinical outcomesFulvio Braido, Giovanni Melioli, Gabriele Nicolini, et al.Drugs in Context|May 31, 2024
Rapid response on facial psoriasis to bimekizumab: case seriesNicoletta Bernardini, Annunziata Dattola, Giacomo Caldarola, et al.Pageof 56